+499.5%
MRNA vs UDR
-1.4%
+500.9%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | UDR | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.2% | 0.0% | -2.3% | -2.3% |
| 7D | +5.5% | -2.0% | +7.5% | +7.1% |
| 30D | +158.7% | -5.2% | +163.9% | +166.6% |
| 3M | +182.1% | -5.8% | +187.9% | +191.2% |
| 6M | +151.8% | -1.7% | +153.5% | +157.2% |
| YTD | +393.6% | +2.4% | +391.2% | +386.4% |
| 1Y | +499.5% | -2.1% | +501.6% | +505.1% |
| All | +499.5% | -1.4% | +500.9% | +505.1% |
Cumulative growth
Daily Returns
Daily percentage return beside UDR.
Daily Out/Under-Performance
Portfolio return minus UDR return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × UDR return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded UDR wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling